Indo Global Journal of Pharmaceutical Sciences: Announcements https://igjps.com/index.php/IGJPS <p>IGJPS is an international journal online. It is interdisciplinary and aims to bring together different approaches for a diverse readership all over the world in pharmaceutical sciences. This Journal publishes original research work that contributes significantly to further the scientific knowledge in pharmacy and pharmaceutical sciences (Pharmaceutical Technology, Pharmacognosy, Natural Product Research, Pharmaceutics, Novel Drug Delivery, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest). The Journal publishes original research work either as a Full Research Paper or as a Short Communication. Review Articles on a current topic in the said fields are also considered for publication by the Journal.</p> en-US Tue, 13 Sep 2022 12:09:43 +0000 OJS 3.3.0.8 http://blogs.law.harvard.edu/tech/rss 60 A new malpractice being observed: Reviewers asking their own papers to cite https://igjps.com/index.php/IGJPS/announcement/view/3 <p>We strongly condemn the method adopted by the reviewers to increase the citations of their own published papers. We have observed that while reviewing, reviewers mention their own papers and ask authors to cite those papers while revising the manuscript.<br />Considering that adding the reviewer's papers will increase the chance of acceptance, so that author's do not argue and simply add those papers. But this is a serious offense and editors have reported such cases very often these days.<br />We strongly condemn and depreciate such behavior of the reviewers. We suggest all such reviewers to stop such practices, not only while reviewing the articles in Indo Global Journal of Pharmaceutical Sciences, but also for all the journals and publishers. Such practice of citations increase will not actually make your work impactful. If your work will be good, it will surely be read and cited by other authors. So, be patient and be ethical while reviewing the papers.<br />Regards<br />Dr. Rajeev K Singla<br />Editor-in-Chief<br /><a href="https://lnkd.in/dQh3py8e" data-attribute-index="4">https://lnkd.in/dQh3py8e</a><br /><a href="https://www.linkedin.com/feed/hashtag/?keywords=reviewer&amp;highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6975423849571979265" data-attribute-index="0">#Reviewer</a> <a href="https://www.linkedin.com/feed/hashtag/?keywords=citation&amp;highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6975423849571979265" data-attribute-index="1">#Citation</a> <a href="https://www.linkedin.com/feed/hashtag/?keywords=malpractice&amp;highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6975423849571979265" data-attribute-index="2">#malpractice</a> <a href="https://www.linkedin.com/feed/hashtag/?keywords=pharmaceutical&amp;highlightedUpdateUrns=urn%3Ali%3Aactivity%3A6975423849571979265" data-attribute-index="3">#pharmaceutical</a></p> https://igjps.com/index.php/IGJPS/announcement/view/3 Tue, 13 Sep 2022 12:09:43 +0000 100% APC waiver for Monkeypox related paper https://igjps.com/index.php/IGJPS/announcement/view/2 <div class="kvgmc6g5 cxmmr5t8 oygrvhab hcukyx3x c1et5uql ii04i59q"> <div dir="auto">Good News For Authors</div> </div> <div class="cxmmr5t8 oygrvhab hcukyx3x c1et5uql o9v6fnle ii04i59q"> <div dir="auto">100% APC waiver for Monkeypox related paper in <a class="oajrlxb2 g5ia77u1 qu0x051f esr5mh6w e9989ue4 r7d6kgcz rq0escxv nhd2j8a9 nc684nl6 p7hjln8o kvgmc6g5 cxmmr5t8 oygrvhab hcukyx3x jb3vyjys rz4wbd8a qt6c0cv9 a8nywdso i1ao9s8h esuyzwwr f1sip0of lzcic4wl gpro0wi8 q66pz984 b1v8xokw" tabindex="0" role="link" href="https://www.facebook.com/iglobaljournal/?__cft__[0]=AZWdFYkvqx4V67pAxeOzO7Y_8689UWyCngOGl1W7nkKiLdD_MWy4BuRahgmgOjX2NocNWJPbfo82hTxIdoHtUsrmljeotf71PWnx_7ImYOhFEsquw3n2Wy2kKeI1MiWUrf_q6GiQ4_u-OCm_vGfsg89LhAY_eo9Dnydx5fsFcznov2h8m1X7BwPOEjrJIPgcLa0&amp;__tn__=kK-R"><span class="nc684nl6">Indo Global Journal of Pharmaceutical Sciences</span></a></div> <div dir="auto">Last Date: 20.08.2022</div> </div> <div class="cxmmr5t8 oygrvhab hcukyx3x c1et5uql o9v6fnle ii04i59q"> <div dir="auto">Register and submit at</div> <div dir="auto"><a class="oajrlxb2 g5ia77u1 qu0x051f esr5mh6w e9989ue4 r7d6kgcz rq0escxv nhd2j8a9 nc684nl6 p7hjln8o kvgmc6g5 cxmmr5t8 oygrvhab hcukyx3x jb3vyjys rz4wbd8a qt6c0cv9 a8nywdso i1ao9s8h esuyzwwr f1sip0of lzcic4wl gpro0wi8 py34i1dx" tabindex="0" role="link" href="https://igjps.com/?fbclid=IwAR02PWzX14JRDhdOHxIjkhDije0jd60W5eTOLevxPWZzK0xc49EmavxqxiY" target="_blank" rel="nofollow noopener">Https://igjps.com</a></div> </div> https://igjps.com/index.php/IGJPS/announcement/view/2 Mon, 08 Aug 2022 09:21:26 +0000 100% APC Waiver for Authors from “Group A” Category Countries Indicated by Research4Life https://igjps.com/index.php/IGJPS/announcement/view/1 <p><strong>We have observed the policies of <a href="https://www.research4life.org/">Research4Life</a> and would like to comply with their objectives by providing 100% APC waivers to the authors belonging to the countries from “Group A” categories. In order to be eligible, the first author and corresponding author should be from the “Group A” category countries. The purpose is to support those researchers and remove the hindrance of Article Processing Charges for them. </strong></p> <p><strong>Group A countries are as below:</strong></p> <table> <tbody> <tr> <td> <ul> <li>Afghanistan</li> <li>Angola</li> <li>Bangladesh</li> <li>Belize</li> <li>Benin</li> <li>Bhutan</li> <li>Burkina Faso</li> <li>Burundi</li> <li>Cambodia</li> <li>Cameroon</li> <li>Cabo Verde</li> <li>Central African Republic</li> <li>Chad</li> <li>Comoros</li> <li>Congo</li> <li>Cook Islands</li> <li>Côte d’Ivoire</li> <li>Democratic People’s Republic of Korea</li> <li>Democratic Republic of the Congo</li> <li>Djibouti</li> <li>Dominica</li> <li>Equatorial Guinea</li> <li>Eritrea</li> <li>Eswatini</li> <li>Ethiopia</li> <li>Gambia</li> <li>Ghana</li> <li>Grenada</li> <li>Guinea</li> <li>Guinea-Bissau</li> <li>Guyana</li> <li>Haiti</li> <li>Kenya</li> <li>Kiribati</li> <li>Kyrgyzstan</li> <li>Lao People’s Democratic Republic</li> <li>Lesotho</li> <li>Liberia</li> <li>Madagascar</li> <li>Malawi</li> <li>Maldives</li> </ul> </td> <td> <ul> <li>Mali</li> <li>Marshall Islands</li> <li>Mauritania</li> <li>Micronesia (Federated States of)</li> <li>Mozambique</li> <li>Myanmar</li> <li>Nauru</li> <li>Nepal</li> <li>Nicaragua</li> <li>Niger</li> <li>Niue</li> <li>Palau</li> <li>Papua New Guinea</li> <li>Republic of Moldova</li> <li>Rwanda</li> <li>Saint Helena</li> <li>Saint Lucia</li> <li>Saint Vincent and the Grenadines</li> <li>Samoa</li> <li>Sao Tome and Principe</li> <li>Senegal</li> <li>Sierra Leone</li> <li>Solomon Islands</li> <li>Somalia</li> <li>South Sudan</li> <li>Sudan</li> <li>Suriname</li> <li>Syrian Arab Republic</li> <li>Tajikistan</li> <li>Timor-Leste</li> <li>Togo</li> <li>Tokelau</li> <li>Tonga</li> <li>Tuvalu</li> <li>Uganda</li> <li>United Republic of Tanzania</li> <li>Vanuatu</li> <li>Yemen</li> <li>Zambia</li> <li>Zimbabwe</li> </ul> </td> </tr> </tbody> </table> <p><strong>This policy will be effective from 13th May 2022 and will be applicable for all the publications submitted from 2022 onwards. </strong></p> https://igjps.com/index.php/IGJPS/announcement/view/1 Mon, 08 Aug 2022 09:14:24 +0000